ATARAXONE, created in 1959 (Belgium), from 359 sister brands and 2214 competing brands. ATARAXONE is owned by UCB, listed on the stock exchange of Bruxelles The International Securities Identification Number (ISIN) of UCB is BE0003739530. ATARAXONE is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
UCB
(ATARAXONE)
over 5 years*
EUR 168.97